Enviva Partners LP (EVA):企業の財務・戦略的SWOT分析

◆英語タイトル:Enviva Partners LP (EVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8013645
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月21日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:エネルギー
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Enviva Partners LP (EVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Enviva Partners LP (Enviva) is a supplier of utility-grade wood pellets. The company aggregates a natural resource, wood fiber, and processes it into a transportable form. Its products include processed woody biomass fuels, wood pellets, and wood chips. Enviva has industrial-scale production plants in the Mid-Atlantic and the Gulf Coast regions of the US. The company also has access to waterways and rail to transport and sells wood pellets to power plants in the UK and Europe. It also provides terminaling services for its production, third-party wood pellet producers and for owners of other bulk commodities. Enviva is headquartered in Bethesda, Maryland, the US.

Enviva Partners LP Key Recent Developments

Aug 17,2016: NORDEN, Enviva sign long-term contracts for transatlantic transport of wood pellets
Aug 04,2016: Enviva Partners, LP Reports Strong Financial Results for Second Quarter 2016
Jun 02,2016: Enviva Partners, LP Signs Long-Term Off-take Contract
May 05,2016: Enviva Partners, LP Reports Increased Financial Results for First Quarter 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Enviva Partners LP – Key Facts 5
Enviva Partners LP – Key Employees 6
Enviva Partners LP – Key Employee Biographies 7
Enviva Partners LP – Major Products and Services 8
Enviva Partners LP – History 9
Enviva Partners LP – Company Statement 10
Enviva Partners LP – Locations And Subsidiaries 13
Head Office 13
Section 2 – Company Analysis 14
Enviva Partners LP – Business Description 14
Enviva Partners LP – SWOT Analysis 15
SWOT Analysis – Overview 15
Enviva Partners LP – Strengths 15
Enviva Partners LP – Weaknesses 16
Enviva Partners LP – Opportunities 17
Enviva Partners LP – Threats 18
Enviva Partners LP – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Recent Developments 27
Aug 17, 2016: NORDEN, Enviva sign long-term contracts for transatlantic transport of wood pellets 27
Aug 04, 2016: Enviva Partners, LP Reports Strong Financial Results for Second Quarter 2016 28
Jun 02, 2016: Enviva Partners, LP Signs Long-Term Off-take Contract 30
May 05, 2016: Enviva Partners, LP Reports Increased Financial Results for First Quarter 2016 31
Section 5 – Appendix 33
Methodology 33
Ratio Definitions 33
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Enviva Partners LP, Key Facts 5
Enviva Partners LP, Key Employees 6
Enviva Partners LP, Key Employee Biographies 7
Enviva Partners LP, Major Products and Services 8
Enviva Partners LP, History 9
Enviva Partners LP, Key Competitors 19
Enviva Partners LP, Ratios based on current share price 20
Enviva Partners LP, Annual Ratios 21
Enviva Partners LP, Annual Ratios (Cont...1) 22
Enviva Partners LP, Annual Ratios (Cont...2) 23
Enviva Partners LP, Interim Ratios 25
Currency Codes 33
Capital Market Ratios 33
Equity Ratios 34
Profitability Ratios 34
Cost Ratios 35
Liquidity Ratios 35
Leverage Ratios 36
Efficiency Ratios 36

★海外企業調査レポート[Enviva Partners LP (EVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Actua Corporation:企業のM&A・事業提携・投資動向
    Actua Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Actua Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Boston Children’s Hospital:医療機器:M&Aディール及び事業提携情報
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • MedMira Inc (MIR)-医療機器分野:企業M&A・提携分析
    Summary MedMira Inc (MedMira) is a medical device company that offers rapid diagnostics and technology solutions. The company offers products in areas of HIV, H. pylori, syphilis, multiplex, miriad rvf toolkit, and tissue and eye banks. It offers testing products for HIV, H. Pylori and syphilis, bes …
  • Societe Tunisienne de l’Electricite et du Gaz:企業の戦略的SWOT分析
    Societe Tunisienne de l'Electricite et du Gaz - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • PCI Pharma Services-製薬・医療分野:企業M&A・提携分析
    Summary PCI Pharma Services (PCI) is a drug development company that offers clinical manufacturing and packaging solutions. The company offers clinical services such as pharmaceutical development, clinical trial manufacturing, clinical trial packaging, clinical supplies management, clinical planning …
  • Acura Pharmaceuticals Inc (ACUR)-医療機器分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • Neuwave Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary NeuWave Medical Inc (NeuWave Medical), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. The company’s product Certus 140 microwave ablation (coagulation) system is a minimally invasive soft tissue abl …
  • Lebara Group:企業の戦略的SWOT分析
    Lebara Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • El Paso Electric Company (EE)-エネルギー分野:企業M&A・提携分析
    Summary El Paso Electric Company (El Paso) is a vertically integrated electric utility which generates, transmits, and distributes electric power. It produces electricity from nuclear, natural gas, coal, and solar sources. The company has ownership interest in and operates various power generation f …
  • Wesfarmers Ltd (WES):企業の財務・戦略的SWOT分析
    Wesfarmers Ltd (WES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orange SA:戦略・SWOT・企業財務分析
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Memphasys Ltd (MEM):製品パイプライン分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen samp …
  • Molecular Partners AG (MOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that provides biological drugs. The company provides advanced pipeline products such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet …
  • Laboratoire Aguettant SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoire Aguettant (Aguettant) is a pharmaceutical company that offers development, manufacturing and commercialisation of essential hospital medicines. The company offers products under various categories such as specialist sectors and delivery systems. Its speciality sector offers emerg …
  • Kinder Morgan, Inc.:企業の戦略・SWOT・財務分析
    Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kinder Morgan, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sanquin Blood Supply Foundation-医療機器分野:企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • OTP Bank Nyrt:企業の戦略・SWOT・財務分析
    OTP Bank Nyrt - Strategy, SWOT and Corporate Finance Report Summary OTP Bank Nyrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Maruti Suzuki India Ltd (MARUTI):企業の財務・戦略的SWOT分析
    Maruti Suzuki India Ltd (MARUTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • The British United Provident Association Ltd-製薬・医療分野:企業M&A・提携分析
    Summary The British United Provident Association Ltd (Bupa) is a leading global healthcare group. It offers health insurance and other funding products, chronic disease management services, home healthcare services, workplace health services and care services, comprising residential and nursing home …
  • Cellectis SA (ALCLS):企業の財務・戦略的SWOT分析
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆